China approved nearly 600 infant formulas in 2023 – new national standards data By Tingmin Koe 07-Aug-2024 - Last updated on 07-Aug-2024 at 03:09 GMT Facebook Twitter Linkedin Email to a friend China approved nearly 600 infant formulas based on the new GuoBiao (GB) or national standards last year.Read the full story here. NIA top stories monthly Melrose Health’s new longevity-focused supplements seek to address decreasing health span, increasing chronic disease incidence in Australia Uncle Frog’s Mushroom Gummies recall: THC likely cause of hospitalisations in Australia - Experts India’s food and drug authorities in talks over which body controls vitamins and minerals above RDA Kobayashi knock-on effect: Japanese functional foods businesses legally bound to four new rules from Sep New Zealand’s Ārepa files new health claims, repackages products to overcome compliance difficulty Australia aims to take back China’s no. 1 health supplements exporter spot from the US China trends data: Bone and joint the mainstay, growing attention on fish oil, novel ingredient NPD Growth Asia Summit 2024 'big bets’: Amway highlights preventive health, plant protein and community building as key strategic focus areas Japan, South Korea top omega-3 index, while China, Australia lower than average – 2024 data China approved nearly 600 infant formulas in 2023 – new national standards data Prev 1 … 7 8 9 10 11 Next
